• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.07% Nasdaq Up0.05%

    Neurocrine Biosciences Inc. (NBIX)

    -NasdaqGS
    22.36 Down 0.41(1.80%) 10:59AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue -   -   -   730  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   730  
    Operating Expenses
    Research Development12,194  10,161  8,572  8,918  
    Selling General and Administrative4,663  4,200  4,153  3,342  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (16,857) (14,361) (12,725) (11,530)
    Income from Continuing Operations
    Total Other Income/Expenses Net982  980  883  888  
    Earnings Before Interest And Taxes(15,875)(13,381)(11,842)(10,642)
    Interest Expense -   -   -   -  
    Income Before Tax(15,875)(13,381)(11,842)(10,642)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(15,875)(13,381)(11,842)(10,642)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (15,875) (13,381) (11,842) (10,642)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (15,875) (13,381) (11,842) (10,642)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.